- Prostate cancer mortality in the finnish randomized screening trialTuomas P Kilpeläinen
Department of Urology, University of Tampere and Tampere University Hospital, Box 2000, FI 33521 Tampere, Finland
J Natl Cancer Inst 105:719-25. 2013..Conclusions At 12 years, a relatively conservative screening protocol produced a small, non-statistically significant PC-specific mortality reduction in the Finnish trial, at the cost of moderate overdiagnosis...
- False-positive screening results in the European randomized study of screening for prostate cancerTuomas P Kilpeläinen
Dept of Urology, Tampere University Hospital and University of Tampere, Finland
Eur J Cancer 47:2698-705. 2011..We describe the frequency of FP results and assess their relation to subsequent screening attendance, test results and prostate cancer risk in a large randomized trial...
- False-positive screening results in the Finnish prostate cancer screening trialT P Kilpeläinen
Department of Urology, University of Tampere and Tampere University Hospital, Box 2000, Tampere FIN 33521, Finland
Br J Cancer 102:469-74. 2010..We investigated the proportion of FPs in a population-based randomised screening trial in Finland...
- Results of the three rounds of the Finnish Prostate Cancer Screening Trial--the incidence of advanced cancer is decreased by screeningTuomas P Kilpeläinen
Department of Urology, Tampere University Hospital and University of Tampere, FIN 33521 Tampere, Finland
Int J Cancer 127:1699-705. 2010..When compared with the CA, the PC detected in the SA there were substantially more often localized, low-grade PCs due to overdiagnosis...